Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2025-04-09

Clinical Trial Update: THE IPI - Trial in Advanced Melanoma: Melanoma Patients With Advanced Disease [Phase 2]

View source ↗

Summary

Phase 2 trial titled THE IPI - Trial in Advanced Melanoma studied ocular melanoma; the study status is COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Prof. Dr. med. Dirk Schadendorf | Conditions: Ocular Melanoma | Phase 2 | Status: COMPLETED